Page 12 - Vitamin D and Cancer
P. 12
Contributors xi
Juergen K.V. Reichardt
Plunket Chair of Molecular Biology (Medicine),
Bosch Institute, The University of Sydney,
Medical Foundation Building (K25), 92–94 Parramatta Road,
Camperdown, NSW 2006, Australia
and
School of Pharmacy and Molecular Sciences, James Cook University,
Townsville, Qld 4811, Australia
Robert Scragg Ph.D.
Associate Professor, School of Population Health, University of Auckland,
Auckland Mail Centre, Private Bag 92019, Auckland 1142, New Zealand
George P. Studzinski M.D., Ph.D.
Professor, Department of Pathology & Laboratory Medicine, UMDNJ-New Jersey
Medical School, 185 So. Orange Avenue, MSB C-540, Newark, NJ 07101-1709, USA
Annette Sunga M.D., MPH
Assistant Professor of Oncology, Roswell Park Cancer Institute, Elm & Carlton
Streets, Buffalo, NY 14263, USA
James Thorne
Division of Experimental Haematology, University of Leeds, Leeds Institute
of Molecular Medicine, Wellcome Trust Brenner Building, St James’s University
Hospital, Leeds LS9 7TF, UK
Donald L. Trump M.D.
President & CEO, Roswell Park Cancer Institute, Elm & Carlton Streets,
Buffalo, NY 14263, USA
Reinhold Vieth Ph.D.
Departments of Nutritional Sciences, and Laboratory Medicine and Pathobiology,
University of Toronto, Ontario, M5G 1X5, Canada
JoEllen Welsh Ph.D.
GenNYsis Center for Excellence in Cancer Genomics, University of Albany,
Rensselaer, NY 12144, USA
Glendon M. Zinser Ph.D.
Department of Cancer & Cell Biology, Vontz Center for Molecular Studies,
3125 Eden Avenue, Cincinnati, OH 45267–0521, USA